Biogen Inc. revenue increases to $2,463 million in quarter ended Mar 31, 2023 from previous quarter
By USInMinutes - Apr 25, 2023, 07:21 PM ET
Last Updated - Jul 18, 2023, 03:49 PM EDT
Key fundamental financials
profit of $387.60 million
Revenue of $2,463 million
earnings per share of $2.67
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$2,463 million
$387.60 million
profit
Sep 2022
$2,508.50 million
$1,134.90 million
profit
Jun 2022
$2,589.10 million
$1,058.70 million
profit
Biogen Inc. [BIIB] has reported $387.60 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $2.67 per share.
Revenue for the quarter was $2,463 million.
The Cambridge, Massachusetts (MA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $13,796.60 million.
